Page last updated: 2024-08-24

anisodamine and butylscopolammonium bromide

anisodamine has been researched along with butylscopolammonium bromide in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, BY; Lü, TP; Yin, GH; You, XK; Zhang, ZJ	1
Jin, JZ; Kong, J; Wang, W; Wu, SD; Zhang, Q	1
Du, YQ; Guo, XZ; Hou, XH; Jiang, F; Li, ZS; Wang, RQ; Xu, H; Zeng, Y; Zhu, CP	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1

Trials

2 trial(s) available for anisodamine and butylscopolammonium bromide

Article	Year
Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry. Hepatobiliary & pancreatic diseases international : HBPD INT, 2003, Volume: 2, Issue:1 Topics: Adult; Aged; Atropine; Butylscopolammonium Bromide; Cholinergic Antagonists; Drug Antagonism; Endoscopy, Digestive System; Female; Humans; Male; Manometry; Middle Aged; Morphine; Narcotics; Pressure; Receptors, Cholinergic; Solanaceous Alkaloids; Sphincter of Oddi	2003
Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm-like pain: A randomized, double-blinded, multicenter Phase III trial. Journal of digestive diseases, 2017, Volume: 18, Issue:8 Topics: Abdominal Pain; Acute Pain; Adult; Butylscopolammonium Bromide; Colic; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Solanaceous Alkaloids; Spasm; Treatment Outcome	2017

Article

Year

Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2003, Volume: 2, Issue:1

Topics: Adult; Aged; Atropine; Butylscopolammonium Bromide; Cholinergic Antagonists; Drug Antagonism; Endoscopy, Digestive System; Female; Humans; Male; Manometry; Middle Aged; Morphine; Narcotics; Pressure; Receptors, Cholinergic; Solanaceous Alkaloids; Sphincter of Oddi

2003

Comparison of efficacy and safety of hyoscine butylbromide versus anisodamine for acute gastric or intestinal spasm-like pain: A randomized, double-blinded, multicenter Phase III trial.

Journal of digestive diseases, 2017, Volume: 18, Issue:8

Topics: Abdominal Pain; Acute Pain; Adult; Butylscopolammonium Bromide; Colic; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Solanaceous Alkaloids; Spasm; Treatment Outcome

2017

Other Studies

2 other study(ies) available for anisodamine and butylscopolammonium bromide

Article	Year
PVC membrane electrodes of anisodamine, N-butylscopolamine and homatropine. The Analyst, 1988, Volume: 113, Issue:1 Topics: Butylscopolammonium Bromide; Electrodes; Membranes, Artificial; Polyvinyl Chloride; Scopolamine Derivatives; Solanaceous Alkaloids; Tropanes	1988
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012

Article

Year

PVC membrane electrodes of anisodamine, N-butylscopolamine and homatropine.

The Analyst, 1988, Volume: 113, Issue:1

Topics: Butylscopolammonium Bromide; Electrodes; Membranes, Artificial; Polyvinyl Chloride; Scopolamine Derivatives; Solanaceous Alkaloids; Tropanes

1988

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012